Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 17, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Lung cancer staging: proteomics.

David H Harpole1, Shari L Meyerson

  • 1Department of Surgery, Duke University Medical Center, Box 8627, 2400 Pratt Street, Room 0311, Durham, NC 27710, USA. harpo002@mc.duke.edu

Thoracic Surgery Clinics
|January 24, 2007
PubMed
Summary

Proteomic profiling shows promise for noninvasive lung cancer diagnosis and survival prediction. This approach could lead to early detection and personalized cancer treatments via targeted therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thoracic Surgery Outcomes Research Network (ThORN) Consensus Document on Defining a High-Quality Wedge Resection for Early-Stage Lung Cancer.

The Annals of thoracic surgery·2025
Same author

Going to MARS may shorten our patient's survival.

The Journal of thoracic and cardiovascular surgery·2024
Same author

Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR).

Practical radiation oncology·2024
Same author

Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2024
Same author

The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.

The Annals of thoracic surgery·2024
Same author

Thoracic Surgical Oncology Group: An American Association for Thoracic Surgery Clinical Trials Initiative.

The Journal of thoracic and cardiovascular surgery·2024

Area of Science:

  • Oncology
  • Proteomics
  • Molecular Diagnostics

Background:

  • Recent technological advancements enable widespread proteomic and genomic analyses.
  • Significant progress has been made in understanding the molecular underpinnings of lung cancer.

Purpose of the Study:

  • To explore the potential of proteomic profiling for noninvasive lung cancer diagnosis.
  • To assess the accuracy of proteomic profiling in predicting patient survival.
  • To identify potential therapeutic targets based on proteomic profiles.

Main Methods:

  • Utilizing proteomic profiling techniques.
  • Analyzing protein expression patterns in lung cancer patients.
  • Correlating proteomic data with clinical outcomes and survival rates.

Main Results:

  • ACOSOG Z4031 study results offer landmark data on proteomic profiling's utility.
  • Proteomic profiling demonstrates potential for accurate noninvasive lung cancer diagnosis.
  • The study highlights the ability of proteomic profiling to predict survival more accurately.

Conclusions:

  • Proteomic profiling is a valuable tool for lung cancer diagnosis and prognosis.
  • Identified protein profiles associated with poor prognosis can serve as therapeutic targets.
  • Future applications may include early diagnosis via blood tests and personalized chemotherapy selection.

More Related Videos

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jul 17, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025